[16日ロイター] - 米バイオ医薬品大手モデルナ(MRNA.O), opens new tabは16日、開発を進めている、メッセンジャーRNA（mRNA）テクノロジーに基づく季節性インフルエンザワクチンについて、臨床試験がまちまちだったと発表した。A型では強い ...

小高い丘を切り開いた土地は緑に囲まれ、田畑の先には太平洋が見える。この自然に囲まれた福島県南相馬市の工業団地に7月末、mRNA（メッセンジャーRNA）医薬品の原薬を製造する工場が完成した。 mRNAとは、体内のタンパク質をつくり出す過程で、DNAが持つ ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines. As the building ...

この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2022年9月1日（現地時間）に発表したものを日本語に翻訳したもので、報道関係者の皆さまに参考資料として提供するものです。資料の内容および解釈については、英語が優先されます。英語版は ...

painkiller Nov. 27, 2022 09:55 am JST The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer with BioNTech, and by Moderna. It delivers ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, a fierce debate has taken place around the future of mRNA-based vaccines ...

Researchers say the COVID-19 pandemic has provided an opportunity to boost a technology that may hold great promise for a new era of medicine. Watch the webinar mRNA technology has become a hot topic ...

an mRNA vaccine that uses messenger RNA (mRNA), and although the technology has been developed for 30 years, it is also the first mRNA vaccine to be put into practical use along with the Pfizer ...

This file photo shows a Moderna COVID-19 vaccine. (Mainichi/Daisuke Wada) The Mainichi Shimbun answers some common questions readers may have about the quick development of COVID-19 vaccines. Question ...